A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome

NCT04752566 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Guillain-Barre Syndrome

Interventions

BIOLOGICAL: Eculizumab
DRUG: Placebo

Sponsor

Alexion Pharmaceuticals, Inc.